Tocilizumab News
Tocilizumab currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Tocilizumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: RoActemra, in combination with methotrexate (MTX), is indicated for the treatment of severe, active and progressive rheumatoid arthritis (RA) in adults not previously treated with MTX. the treatment...
- Evidence level: L1
- Predicted indications (20):
- ankylosing spondylitis (100.0%)
- rheumatoid vasculitis (100.0%)
- hypermobility of coccyx (100.0%)
- spondyloarthropathy, susceptibility to (100.0%)
- inflammatory spondylopathy (100.0%)
- Kummell disease (100.0%)
- polyarticular juvenile rheumatoid arthritis (100.0%)
- vertebral disease (99.9%)
- juvenile idiopathic arthritis (99.9%)
- mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency (99.9%)
- rheumatoid factor-positive polyarticular juvenile idiopathic arthritis (99.9%)
- rheumatoid nodulosis (99.8%)
- juvenile chronic polyarthritis (99.8%)
- juvenile arthritis due to defect in LACC1 (99.7%)
- autosomal recessive familial Mediterranean fever (99.5%)
- anti-glomerular basement membrane disease (99.2%)
- WHIM syndrome (99.2%)
- systemic mastocytosis (99.1%)
- familial Mediterranean fever, autosomal dominant (99.1%)
- psoriasis-related juvenile idiopathic arthritis (99.0%)
Related News (2)
A surprisingly simple way to relieve knee arthritis pain without pills or surgery - Science Daily
2026-10-11 arthritis
Source: Science Daily
Knee pain and crunching: 3 exercises to ease osteoarthritis of the kneecap - South China Morning Post
2026-10-09 arthritis
Source: South China Morning Post
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.